# Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14

> **NCT00000262** · NA · COMPLETED · sponsor: **University of Chicago** · enrollment: 20 (actual)

## Conditions studied

- Opioid-Related Disorders
- Substance-Related Disorders

## Interventions

- **DRUG:** 30% Nitrous oxide
- **DRUG:** 0.4% Sevoflurane
- **DRUG:** 0.2% sevoflurane
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00000262
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-11
- **Primary completion:** 1999-02
- **Final completion:** 1999-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000262, "Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*